Trial Profile
Changes in adiposity and metabolic measures during medication switches to aripiprazole from other atypical antipsychotics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Olanzapine; Quetiapine; Risperidone
- Indications Schizophrenia
- Focus Pharmacodynamics
- Acronyms BMS
- 26 Jun 2010 Results presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 06 Apr 2010 Actual end date (1 Aug 2009) added as reported by ClinicalTrials.gov record.
- 06 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.